Abstract—One of the pathophysiological mechanisms of the development of some mental diseases, including depressive disorders, is a decrease in the expression of brain-derived neurotrophic factor (BDNF), mainly in the limbic region and prefrontal cortex of the brain. Immunochemical screening of BDNF in biological fluids showed that the levels of this protein can be considered as a marker of predisposition to depression and a prognostic marker of the effectiveness of therapy. The use of modern technologies for the production of recombinant proteins makes it possible to develop highly standardized ELISA systems for the determination of this antigen in biological fluids. This paper describes a method for creating a test system for quantitative ELISA of brain-derived neurotrophic factor on the basis of recombinant protein BDNF and antibodies obtained as a result of immunization with recombinant BDNF.
REFERENCES
Kessler, R.C. and Bromet, E.J., Annu. Rev. Public Healt., 2013, vol. 34, pp. 119–138.
Stetler, C. and Miller, G.E., Psychosom. Med., 2011, vol. 73, no. 2, p. 114–126.
Irwin, M.R. and Miller, A.H., Brain Behav. Immun., 2007, vol. 21, no. 4, pp. 374–383.
Grigor'yan, G.A., Dygalo, N.N., Gekht, A.B., Stepanichev, M.Yu., and Gulyaeva, N.V., Usp. Fiziol. Nauk, 2014, vol. 45, no. 2, pp. 3–19.
Sullivan, P.F., Agrawal, A., Bulik, C.M., Andreassen, O.A., Borglum, A.D., Breen, G., Cichon, S., Edenberg, H.J., Faraone, S.V., Gelernter, J., Mathews, C.A., Nievergelt, C.M., Smoller, J.W., and O’Donovan, M.C., Am. J. Psychiatry, 2018, vol. 175, no. 1, pp. 15–27.
Yang, T., Nie, Z., Shu, H., Kuang, Y., Chen, X., Cheng, J., Yu, S., and Liu, H., Front Cell. Neurosci., 2020, vol. 14.
Barde, Y.A., Edgar, D., and Thoenen, H., EMBO J., 1982, vol. 1, no. 5, p. 549–553.
Kowianski, P., Lietzau, G., Czuba, E., Waskow, M., Steliga, A., and Morys, J., Cell. Mol. Neurobiol., 2018, vol. 38, pp. 579–593.
Gulyaeva, N.V., Biokhimiya, 2017, vol. 82, no. 3, pp. 441–448
Taliaz, D., Stall, N., Dar, D.E., and Zangen, A., Mol. Psychiatry, 2010, vol. 15, no. 1, pp. 80–92.
Filho, C.B., Jesse, C.R., Donato, F., Giacomeli, R., Del Fabbro, L., Silva, AntunesM., de Gomes, M.G., Goes, A.T., Boeira, S.P., Prigol, M., and Souza, L.C., Neuroscience, 2015, vol. 289, pp. 367–380.
Yoshida, T., Ishikawa, M., Niitsu, T., Nakazato, M., Watanabe, H., Shiraishi, T., Shiina, A., Hashimoto, T., Kanahara, N., Hasegawa, T., Enohara, M., Kimura, A., Iyo, M., and Hashimoto, K., PLoS One, 2012, vol. 7, no. 8, p. e42676.
Duman, R.S., Aghajanian, G.K., Sanacora, G., and Krystal, J.H., Nat. Med., 2016, vol. 22, no. 3, pp. 238–249.
Duman, R.S., Deyama, S., and Fogaca, M.V., Eur. J. Neurosci., 2021, vol. 53, no. pp. 126–139.
Mondal, A.C. and Fatima, M., Int. J. Neurosci., 2019, vol. 129, no. 3, pp. 283–296.
Castren, E. and Kojima, M., Neurobiol. D., 2017, vol. 97, pp. 119—126.
Nobis, A., Zalewski, D., and Waszkiewicz, N., J. Clin. Med., 2020, vol. 9, p. 3793.
Islam, F., Mulsant, B.H., Voineskos, A.N., and Rajji, T.K., Curr. Psychiatry Rep., 2017, vol. 19, no. 7, pp. 36.
Song, J.H., Yu, J.T., and Tan, L., Mol. Neurobiol., 2015, vol. 52, no. 3, pp. 1477–1493.
Nuernberg, G.L., Aguiar, B., Bristot, G., Fleck, M.P., and Rocha, N.S., Transl. Psychiatry, 2016, vol. 6, no. 12, e985.
Jin, W., J. Clin. Med., 2020, vol. 9, no. 1, pp, 257.
Funding
There was no external funding.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest. The authors declare that they have no conflicts of interest.
Ethical approval. All applicable international, national and/or institutional guidelines for the care and use of animals have been followed. All procedures performed in human research comply with the ethical standards of the institutional and/or national research ethics committee and the 1964 Declaration of Helsinki and its subsequent amendments or comparable ethical standards.
Informed consent. Informed consent was obtained from each of the participants included in the study.
Additional information
Corresponding author; address: per. Kropotkinsky, 23, Moscow, 119034 Russia; e-mail: uovnew@mail.ru.
Rights and permissions
About this article
Cite this article
Pavlova, O.V., Murashko, A.A., Andryushchenko, N.V. et al. Development of a Quantitative Enzyme Immunoassay of Brain-Derived Neurotrophic Factor on the Basis of a Recombinant Antigen. Neurochem. J. 17, 132–137 (2023). https://doi.org/10.1134/S1819712423010154
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1134/S1819712423010154